SCHEDULE: Two Seas Capital Discloses 5.7% Stake in Core Scientific

Sentiment:

Schedule 13D Amendment


Two Seas Capital LP has reported a 5.7% beneficial ownership stake in Core Scientific, Inc. through a Schedule 13D filing.

Summary

  • Two Seas Capital LP, Two Seas Capital GP LLC, and Sina Toussi collectively report beneficial ownership of 17,918,778 shares of Core Scientific, Inc. common stock.
  • This holding represents approximately 5.7% of the company's outstanding common stock.
  • The position includes 313,646 shares issuable upon the exercise of warrants and 3,534,000 shares issuable upon the exercise of options.
  • The reporting persons have delegated sole voting and investment power to Two Seas Capital (TSC) via investment management agreements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral disclosure of institutional ownership changes and derivative positioning, which is standard for large-scale investment management firms.

Positives

  • The reporting entity maintains a significant 5.7% stake, indicating a substantial investment interest in the issuer.
  • The filing provides a transparent and detailed breakdown of recent trading activity and option positions.

Negatives

  • The reporting persons hold a complex array of derivative positions, including various put and call options, which may introduce volatility or indicate hedging strategies.
  • The aggregate purchase price for the reported holdings is substantial, totaling over $167 million across various funds and accounts.

Risks

  • The investment involves significant exposure to derivative instruments, including options with varying expiration dates and strike prices.
  • The reporting persons' ability to influence the company's direction is limited by the nature of their investment management agreements.
  • Market volatility in Core Scientific's stock price could significantly impact the value of the reported options and warrants.

Future Outlook

The filing does not provide specific forward-looking guidance for the issuer, focusing instead on the reporting persons' investment activities and derivative positions.

Industry Context

StockSavvy.ai notes that this filing reflects active institutional trading in the digital asset infrastructure sector, where investors often utilize complex derivative strategies to manage exposure to volatile mining stocks.

Comparison to Industry Standards

  • The filing follows standard SEC disclosure requirements for institutional investors exceeding the 5% ownership threshold.
  • The use of complex option strategies is consistent with hedge fund activity in the high-beta cryptocurrency mining industry.

Stakeholder Impact

  • Shareholders should be aware of the significant stake held by Two Seas Capital and the potential for future volatility related to their derivative positions.

Next Steps

  • Continued monitoring of the reporting persons' trading activity in future SEC filings.
  • Observation of the impact of expiring options on the reporting persons' beneficial ownership levels.

Key Dates

DateDescription
03/20/2026Date of previous Schedule 13D amendment.
03/23/2026Date used for calculating outstanding shares.
03/24/2026Start date of reported transactions in this filing.
04/14/2026Date of event requiring the filing of this statement.
04/16/2026Date of filing and signature.
04/17/2026Expiration date for several put and call options.
05/15/2026Expiration date for certain call options.
09/18/2026Expiration date for certain call options.

Keywords

Core Scientific, Two Seas Capital, Schedule 13D, Beneficial Ownership, Common Stock, Derivative Securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.